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We describe a unique extracellular matrix (ECM) niche in the
spleen, the marginal zone (MZ), characterized by the basement
membrane glycoproteins, laminin α5 and agrin, that promotes for-
mation of a specialized population of MZ B lymphocytes that re-
spond rapidly to blood-borne antigens. Mice with reduced laminin
α5 expression show reduced MZ B cells and increased numbers of
newly formed (NF) transitional B cells that migrate from the bone
marrow, without changes in other immune or stromal cell com-
partments. Transient integrin α6β1-mediated interaction of NF B
cells with laminin α5 in the MZ supports the MZ B-cell population,
their long-term survival, and antibody response. Data suggest that
the unique 3D structure and biochemical composition of the ECM
of lymphoid organs impacts on immune cell fate.
B-cell development | immunology
Secondary lymphoid organs are characterized by their uniquepatterns of immune cell compartmentalization, which is im-
portant for their function. Over recent years, the molecular basis
for these distinct compartments within lymph nodes and the
spleen has been intensely studied, revealing a complex in-
terrelationship between cell–cell adhesion molecules, cytokines,
and chemotactic factors. Most such adhesive and chemotactic
factors are expressed by the stromal cells of the nonhemato-
poietic scaffold of secondary lymphoid organs, which constitute
the reticular fiber network. However, little attention has been
given to the acellular component of the reticular fiber network,
and relatively little is known about the nature of this extracellular
matrix (ECM) compartment and its function. In most tissues the
ECM acts to separate cellular compartments and provides scaf-
folds for the adhesion and migration of cells, in the form of
basement membranes or fibrillar interstitial matrices; it provides
molecular cues that control differentiation and proliferation
processes and determines cell survival vs. cell death (anoikis),
either by direct interaction with cells or indirectly due to its large
potential to bind and present cytokines and chemotactic factors
(1). Whether similar functions exist in secondary lymphoid
organs remains largely univestigated.
The reticular fiber network consists of an inner core of fibrillar
collagens, ensheathed by a basement membrane layer and mi-
crofibrillar proteins, and an outer layer of reticular fibroblasts
(2–4). However, the molecular constituents of these layers vary
in reticular fibers of different cellular compartments, and fun-
damental differences exist between the lymph node and spleen
(4). Apart from acting as the structural backbone and potentially
also a scaffold for immigrating cells (5), the reticular fiber net-
work functions as a conduit for small-molecular-weight (<70
kDa) soluble factors (3, 6), which, in the lymph node, permit
rapid delivery of antigens and/or chemokines (5) from the
periphery to the surface of high endothelial venules for re-
cruitment of T lymphocytes (2, 3). Whether other functions exist
is not clear.
Our work focuses on the ECM of the spleen, in particular the
marginal zone (MZ), which is central to spleen function as it
contains a specialized population of B lymphocytes exhibiting
a partially activated phenotype (MZ B cells) that responds rap-
idly to incoming pathogens by secreting large amounts of mainly
IgM in a T cell–independent manner (7). In addition, MZ B cells
continuously shuttle between the MZ and lymphoid follicle
carrying blood-borne antigens into the follicle for presentation
by follicular dendritric cells (FDCs) to follicular (FO) B cells
that, in turn, present antigen to follicular T cells and thereby also
contribute to the adaptive T- and B-cell immune response (8).
Crucial for these functions is the localization of MZ B cells in the
MZ, situated between the marginal sinus marking the border to
the lymphoid follicle and the red pulp (RP), a site of high blood
flow and first encounter with blood-derived pathogens and che-
motactic factors. In addition to MZ B cells, immature dendritic
cells (DCs), marginal zone, and metallophilic macrophages occur
at this site together with specialized stromal cells, whereas
recirculating FO B cells and newly formed (NF) naive B cells,
which stem from the bone marrow and replenish both MZ and
FO B-cell populations, occur transiently in the MZ (9).
Several factors contribute to the localization of matureMZB cells
in the MZ, most important of which are integrin α4β1-vascular
cell adhesion molecule (VCAM)-1 and leukocyte function
associated antigen (LFA)-1–intracellular adhesion molecule
(ICAM)-1 interactions (10), and relative levels of the chemo-
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kines, sphingosine-1-phosphate (S1P) and CXCL13, in the cir-
culation and in the follicle (11). However, there is comparatively
little knowledge about how and indeed whether the MZ micro-
environment influences MZ B-cell development or how the size
of the MZ B-cell pool is regulated. During development, B-cell
precursors develop in the bone marrow and move to the spleen
where they constitute the newly formed immature (transitional)
B cells that give rise to the mature MZ and FO B-cell pop-
ulations (12). This process occurs continuously and also replen-
ishes the MZ and FO B-cell populations in the adult. Signaling
through the B-cell receptor (BCR), Notch2, the receptor for B
cell–activating factor (BAFF) signaling, and the canonical NF-
κB pathway has been shown to be crucial in determining MZ B-
cell fate (13). In addition, factors involved in the migration and
anatomical retention of MZ B cells, such as the B-cell cor-
eceptor, CD19, that associates with the integrin-linked CD9 and
CD81 tetraspanins (14, 15), or the tyrosine kinase, Pyk-2 (16),
are required for establishment of the MZ B-cell population
as, in their absence, no MZ B cells form but FO B cells are
not affected.
We show here that the ECM also distinguishes different im-
mune cell compartments in the spleen and promotes the B-cell
population of the MZ. The MZ is revealed to be a unique ECM
structure that surrounds individual stromal cells and is charac-
terized by the presence of the basement membrane–specific
molecule, laminin α5, and the heparan sulfate proteoglycan,
agrin. In vivo distribution of laminin α5 and agrin precisely
correlate with MZ B-cell localization. However, only reduction
of laminin α5 and not agrin in the MZ of a laminin α5 condi-
tional KO mouse results in reduced MZ B-cell numbers and
concurrent increase in NF B cells migrating into the spleen from
the bone marrow. In vivo and in vitro data suggest that the
presence of laminin α5 in the MZ maintains the MZ B-cell
compartment in an integrin α6β1–dependent manner. We show
that laminin α5 also binds BAFF and leads to clustering and
colocalization of integrin α6β1 and BAFF receptors on the NF B
cells, thereby syngerizing with BAFF to support survival of NF B
cells and the mature MZ B-cell population. Although the ECM
of secondary lymphoid organs can well be envisaged as an im-
portant structural component separating different cell compart-
ments and acting as a scaffold guiding cell movement (17), this is
clear evidence that it can also directly contribute to immune cell
fate and survival.
Results
Laminin α5 Is Predominantly Expressed in the MZ. Using the anti-
bodies listed in Table 1, we characterized the ECM of the spleen,
with a focus on the MZ, revealing the expression of laminin α5
(Fig. 1 A–D) and the heparan sulfate proteoglycan, agrin (Fig. 1
E–G), in the MZ. In addition, laminin α5 is strongly expressed in
basement membranes of the sinus lining endothelium and of blood
vessels in the RP (Fig. 1 A–D). By contrast, other basement
membrane molecules, including nidogen 1, collagen type IV,
ERTR7, and perlecan, are equally distributed throughout the
MZ and the RP (Fig. S1A). Confocal microscopy of immuno-
fluorescently stained sections revealed that laminin α5 and agrin
colocalize in a perifollicular fibrillar network (Fig. 1 E and G),
precisely coincident with IgMhigh/IgDlow MZ B cells (Fig. 1 D
and F) and overlapping with VCAM-1–expressing areas (Fig. 1 H
and I), characteristic of the MZ. This filigree laminin α5 staining
in the MZ colocalized with laminin γ1 and β1 or laminin γ1 and
β2 chains, indicating the existence of laminin isoforms 511 and
521, respectively, and was distinct biochemically, and in fiber
density and dimensions from the staining of reticular fibers in the
follicle and in the RP (Fig. 1H and I; Fig. S1 A–D). In contrast to
reticular fibers of the MZ and RP, those of the white pulp (WP)
contain collagens I and II, whereas ERTR 7 is present in the RP
and MZ but not the B-cell zone of the follicle (4). As a conse-
quence of these biochemical differences, fiber sizes differ in the
MZ, RP, and WP, with mean diameters of <0.5 μm in the RP,
0.5–1 μm in the MZ and 1–2 μm in the WP (Fig. S1 B–D) (4).
Mice with enlarged MZs and higher frequencies of MZ B
cells, including nonobese diabetic (NOD) and the transgenic
24αβNOD mice expressing the CD1d-restricted Vα3.2Vβ9 T-cell
receptor (TCR) (18) (Fig. 2 A and B), showed a broader distri-
bution of the laminin α5 and agrin than control C57BL/6 mice
(Fig. 2C) that correlated with the localization of B220+ cells in
the MZ (Fig. 2B). Conversely, CD19−/− mice, lacking MZ B cells
(19), also lacked laminin α5 in the MZ but showed no change in
agrin staining (Fig. S2). ICAM-1 and VCAM-1 staining patterns
did not differ from those observed in control C57BL/6 mice (Fig.
S2). The closer correlation between MZ B-cell localization and
laminin α5 than with agrin was confirmed in agrin−/− mice (20),
which showed no loss of laminin α5 or disturbances in MZ B-cell
localization or numbers (Fig. S2).
Reduced MZ B-Cell and Increased Newly Formed B-Cell Numbers in
Lama5−/− Spleens. As mice lacking laminin α5 (Lama5−/−) die
embryonically (21), we generated tissue-specific Lama5−/− mice,
some of which show altered laminin α5 localization in the MZ.
We report here on one strain generated by crossing the Tie-2-cre
transgenic strain (22) with mice carrying loxP sites flanking exon
1 of Lama5 (Fig. S3 A–C). The rational for examining the spleen
of the endothelial cell specific Lama5−/− mouse was based on the
expression of several endothelial cell markers in stroma of the
spleen (Fig. S4A) (4). This conditional Lama5−/− mouse showed
significantly reduced laminin α5 in the MZ and in blood vessel
basement membranes in the RP (Fig. 2D) but no difference in
Table 1. ECM primary antibodies used in immunofluorescence
Name of molecule Antibody name/clone Reference/source
Laminin α1 317 (32)
Laminin α2 401 (32)
Laminin α4 377 (32)
Laminin α5 504 (32)
Laminin γ1 3E10 (45)
Laminin β1 3A4 (45)
Laminin β2 Rabbit serum (domain IV) (46)
Pan-laminin 455 (32)
Laminin 332 (composed of laminin α3,γ2,β3) AP1002.3 ImmunDiagnostik
Nidogen 1 Rabbit serum (47)
Nidogen 2 Rabbit serum (48)
Agrin 204 (41)
Perlecan A716 C11L1 (32)
Collagen type IV AB765 (32)
Collagen type I AB756P Chemicon
Collagen type III 1330–01 Southern Biotech
Tenascin-C MTN1 (49)
Fibronectin Chicken serum (RGD-binding) (45)


























agrin, VCAM-1, ICAM-1, and mucosal addressin cell adhe-
sion molecule (MAdCAM)-1 staining compared with littermate
Lama5 floxed/floxed mice (defined as WT controls; Fig. S5A). The
expression of other ECM molecules normally found in MZ and
RP was also unaltered, as was the localization and total numbers
of metallophilic macrophages antibody (MOMA)-1+ sinus lining
macrophages and ERTR9+ MZ macrophages (Fig. S5 A and B).
The residual laminin α5 staining at the marginal sinus of the
Lama5−/− mouse is derived from perivascular cells (Fig. S4 B
and C).
Flow cytometry revealed reduced numbers of CD23low/
CD21high MZ B cells in the conditional Lama5−/− mice com-
pared with WT controls and a concomitant increase in the
CD21low/CD23low NF B cells but no differences in CD23high/
CD21low FO B-cell numbers (Fig. 2E). Analyses of the blood of
Lama5−/− mice confirmed the absence of circulating MZ B cells
and no differences from WT littermates in circulating levels of
total CD45+ cells or B cells (Fig. S5C). However, Lama5−/−mice
showed significantly reduced circulating antibody levels after
immunization with NP-Ficoll, indicating an impaired immuno-
logical response to T cell–independent antigens (Fig. 2F).
Flow cytometry of the bone marrow for pre- and pro-B cells,
newly formed immature B cells, and recirculating B cells, as
determined by their B220/CD19/CD21/CD23/AA4.1/IgM pro-
files (12), revealed no difference between Lama5−/− and WT
mice (Fig. S6A). Spleens of WT and Lama5−/− mice also showed
similar proportions of CD19+/AA4.1+ immature B cells; how-
ever, Lama5−/− mice had increased proportions and absolute
numbers of the “transitional” T1 population and an associated
reduction in the T2 population but no change in the T3 pop-
ulation (Fig. S6B). As the T1 population represents early
immigrants from the bone marrow that develop to the T2 pop-
ulation in the spleen, and T2 contains considerable numbers of
precursors that give rise to the MZ B cells (12), this suggests
a defect in T1 to T2 transition leading to a subsequent decrease
in mature MZ B cells.
Functional Significance of Laminin α5 in the MZ. Newly formed B cells
and MZ B cells show integrin-mediated binding to laminin α5. Flow
cytometry revealed that NF, MZ, and FO B cells all express
integrin subunits that constitute receptors known to recognize
laminin α5, including integrins β3, αv, α5, and α6 (Fig. 3A; Fig.
S7A) (23, 24). In addition, integrins α4, β1, αL, β2, and β7 were
detected on NF (Fig. 3A) and, as previously reported (10), on
MZ and FO B cells (Fig. S7A). Other ECM-binding receptors,
including integrins α1, α2, and α7, dystroglycan, lutheran blood
group glycoprotein (25), and sulphatide (3′-sulphogalacto-
sylceramide) (26), were not detectable on the surface of NF, MZ,
or FO B cells.
To test functional activity of the integrins, in vitro adhesion
assays were performed. NF B cells showed high levels of binding
to laminin 511/521, which exceeded the binding to VCAM-1 and
was abolished by function blocking antibodies to integrins α6
and β1, suggesting involvement of α6β1 (Fig. 3B). MZ and FO B
cells also bound laminin 511/521 but to similar levels as to
VCAM-1 (Fig. 3B), and binding was inhibited by blocking anti-
bodies to integrins β1 and β3 and RGD (Arg-Gly-Asp) peptide
(Fig. S7B), suggesting involvement of integrins α5β1, αvβ3, and/
or αvβ1 (23). This result was substantiated by the use of the
RGD-containing laminin α5 recombinant domain IVa, which
supported binding of MZ and FO B cells, but not of NF B
cells, in an integrin β3– and RGD-dependent manner (Fig. 3B;
Fig. S7B).
NF, MZ, and FO B cells all showed less extensive binding to
agrin and no binding to fibronectin despite expression of several
fibronectin receptors (including α4β1, α5β1, and αvβ3/αvβ1) and
its reported expression in the spleen (27). Taken together, this
suggests that mature and NF B cells can interact directly with
laminin α5 but that different domains are recognized by distinct
receptors on MZ and FO vs. NF B cells, resulting in transduction
of different signals. In vivo dislodgement experiments performed
with antibodies to integrins β1, β3, and α6, laminin α5, or com-
binations thereof, as previously described for anti-αL and α4
integrin antibodies (10), revealed no dislodgement of MZ or FO
B cells from the spleen into the blood (Table S1), suggesting that
binding to laminin α5 does not contribute to long-term locali-
zation of mature B-cell populations to the spleen.
Integrin α6β1-mediated homing of NF B cells to the laminin α5-rich MZ.
The precise localization of immigrating NF B cells in the spleen
is not clear due to the need to simultaneously stain for several
marker molecules for their identification. We therefore used
IgM+CD21low and AA4.1+IgM+ to investigate whether imma-
ture B cells and laminin α5 show any colocalization in vivo. This
examination revealed the presence of IgM+CD21low and
AA4.1+IgM+ cells in the MZ but also in the follicle, RP, and
periarteriolar lymphoid sheaths (PALSs; Fig. 3 C and D), as
reported also by others (28, 29), suggesting at least transient
localization of the NF B cells in the MZ. To more precisely
investigate whether NF B cells can reside in the MZ, NF cells
isolated from spleens of 10-d-old mice were labeled with 5′/6′-
carboxytetramethylrhodamine (TAMRA), and 5 × 106 cells per
mouse were injected i.v. into mature (8–9 wk) mice; spleens were
analyzed 16 h after transfer. TAMRA+ NF B cells were found in
the laminin α5+ MZ but also the FO (at a ratio of 2:3; Fig. 3E);
however, when NF B cells were preincubated with GoH3 (anti-
integrin α6), significantly fewer TAMRA+ cells localized to the
MZ and more accumulated in the FO (ratio of 1:5; Fig. 3E). I.v.-
injected TAMRA-labeled FO B cells homed almost exclusively
to the follicle, and GoH3 had no effect on their localization (Fig.
3E). GoH3 did not affect the total number of host or donor NF
or FO B cells accumulating in the spleen after transfer, in-
dicating that only NF B-cell localization within the spleen was
altered and that there was no displacement of NF or FO B cells
to the circulation (Fig. S8A). Injection of TAMRA+ NF B cells
into Lama5−/− also resulted in accumulation of TAMRA+ cells
in the FO (Fig. S8B). Because Lama5−/− have someMZ B cells, this
suggests that NF B cells can develop to MZ B cells outside of the
MZ but that it is less efficient than in the MZ.
Fig. 1. Immunofluorescence staining for laminin α5, agrin, IgMhigh/IgDlow
MZ B cells, and VCAM-1+ stromal cells in the MZ. (A) Anti–laminin α5 stains
basement membranes of the sinus lining endothelium, blood vessels in the
RP, and the reticular fibers in the WP; (B) higher magnification shows a fili-
gree laminin α5 pattern in the MZ (double arrows) that is distinct from the
thicker reticular fiber staining in the WP. Confocal image of a thick section
(60 μm) stained for laminin α5 (C and D) or agrin (E and F) together with IgM
and IgD showing colocalization of laminin α5 and agrin with IgMhigh MZ
B cells in the MZ. (G) Double staining for laminin α5 and agrin shows that
both occur in the MZ but that laminin α5 has a more extensive distribution in
the WP and in the sinus lining basement membrane. Confocal image of
a thick section (60 μm) stained for laminin α5 and VCAM-1 (H and I) shows
overlap of VCAM-1+ stromal cells in the MZ and the laminin α5 network. CA,
central artery; WP, white pulp; sinus, marginal sinus; MZ, marginal zone; RP,
red pulp. Magnification: A and C–G, 100×; B and H, 200×; I, 400×.








































Integrin α6−/− Bone Marrow Chimera Mice Phenocopy the Lama5−/−
Phenotype. In view of the high expression of integrin α6β1 on NF
B cells and its ability to mediate binding to laminin α5, we
generated bone marrow chimeric mice carrying integrin α6−/−
(Itga6−/−) bone marrow and followed the in vivo reconstitution of
splenic B-cell populations, which was necessary as Itga6−/− mice
die at birth (30). As in the conditional Lama5−/− mouse, the
Itga6−/− chimeras showed reduced MZ B-cell numbers and in-
creased NF B cells, but no difference in FO B-cell numbers (Fig.
4A). The antibody response of the Itga6−/− chimeras to NP-Ficoll
was also impaired, as for the Lama5−/− mouse (Fig. 4B).
Analysis of the AA4.1 population, as a marker of immature B
cells, revealed an enhanced proportion and absolute numbers of
the CD19+CD23− T1 population and a reduced CD19+CD23+
T2/T3 population in the spleen, but no defect in immature B
cells in the bone marrow (Fig. S9 A and B), suggesting a similar
block in the formation of MZ precursor cells only in the spleen
as occurs in mice lacking laminin α5 in the MZ.
Competitive bone marrow reconstitution studies performed
with a 1:1 ratio of CD45.1+ WT:CD45.2+ Itga6−/− bone marrow
cells did not show any developmental defect in bone marrow
B-cell or myeloid populations in the absence of integrin α6 (Fig.
S10 A and B). However, in the spleen, Itga6−/− precursors ac-
cumulated at the NF B-cell stage and were less efficient than WT
precursors in establishment of the MZ B-cell population, but
could constitute the FO B-cell population as efficiently as WT
cells (Fig. 4C).
Laminin α5 Promotes MZ B-Cell Survival. To investigate whether
integrin α6β1-mediated interaction with laminin α5 influences
long-term survival of the mature MZ B cells, flow cytometry for
proportions of TUNEL-positive cells was performed as a mea-
sure of apoptosis, revealing enhanced apoptosis of MZ B cells in
both conditional Lama5−/− and Itga6−/− chimeric spleens (Fig.
5A). This result was confirmed by quantitative RT-PCR (qRT-
PCR) performed on sorted MZ, FO, and NF B cells, revealing
down-regulation of the antiapoptotic (Bcl-XL, Bcl-2) and up-
regulation of proapoptotic (Bim) genes in MZ B cells in both
conditional Lama5−/− (Fig. S11A) and Itga6−/− spleens (Fig. 5B).
As Notch2 is crucial for MZ B-cell development and Deltex1
expression is strictly dependent on that of Notch2 (13), we ex-
amined the expression of Deltex1 mRNA in sorted MZ, FO, and
NF B cells isolated from conditional Lama5−/− and Itga6−/−
chimeric mice spleens, revealing an unexpected up-regulation of
Deltex1 in NF cells in both cases (Fig. 5C; Fig. S11B). Flow
cytometry of sorted NF B cells revealed two populations, one
consisting of small sized cells and a second population consisting
of cells as large as mature MZ B cells, which expressed 10-fold
more Deltex1 than the small NF B cells, at levels comparable to
mature MZ B cells (Fig. 5D; Fig. S11C). Staining for additional
surface markers revealed that the large NF cells were
Fig. 2. Laminin α5 distribution in the MZ correlates with MZ B-cell localization and numbers. (A) Flow cytometry of adult spleens from C57BL/6 mice, NOD,
and 24αβNOD transgenic mice showing an increase in the CD21highCD23low MZ B-cell population in the latter two mouse strains, and (B) associated expansion
of immunofluorescence staining for pan-laminin and B220 in the MZ (double arrows). (C) Expansion of the MZ is associated with broader immunofluorescent
staining for laminin α5 and agrin in the MZ of NOD and 24αβNOD mice. Magnification: top panel in B, 100×; otherwise, 200×. (D) Immunofluorescence
staining of adult spleen sections from conditional Lama5−/− mice and WT littermates for laminin α5, IgM, and IgD showing reduced laminin α5 localization in
the MZ and associated reduction in the IgMhigh/IgDlow MZ B-cell population. Magnification, 150×. (E) Flow cytometry reveals lower frequencies and total
numbers of MZ B cells in Lama5−/− spleens and an increase in CD21low/CD23low NF B cells, but no change in CD21low/CD23high FO B cells. Gated on CD19+ cells.
Quantitative data shown is for three experiments with four to five mice per experiment. (F) Circulating IgM levels in Lama5−/− mice and WT littermates in
response to i.v. or i.p. immunization with T cell–independent antigen (NP-Ficoll). Data shown are means ± SEM from six Lama5−/−mice andWT littermates and
three independent experiments. **P < 0.01; ***P < 0.001.


























IgM+CD1dnegHAShigh and some were also AA4.1+ (Fig. 5E)
and, therefore, probably represent an intermediate de-
velopmental phase between the conventional NF B cells (small)
and MZ B cells. This result suggests that integrin α6β1-mediated
binding to laminin α5 is not a prerequisite for Notch2-dependent
differentiation of NF B cells to MZ B cells, but may act with
other factors to support this differentiation. To test this hy-
pothesis, CD21low/CD23low NF B cells isolated from 10-d-old
mouse spleens were incubated in the presence of soluble laminin
511 or agrin, with and without added BAFF. Agrin also carries
growth factor binding domains but cannot bind integrin α6β1
(31). Cells were incubated for 48 h at 37 °C with the ECM
molecules in the presence or absence of GoH3 anti-integrin α6
or isotype control antibody, and numbers of NF vs. MZ B cells
were measured by flow cytometry; control experiments involved
incubation with BAFF alone or ECM molecules not expressed at
this site (laminin 411). MZ B-cell differentiation was assessed by
determining proportions of CD21high/CD1dhigh and CD23+/
CD21+ cells; IgM/IgD cannot distinguish between NF and MZ B
cells (both IgMhighIgDlow) but permitted investigation of FO B
cells (IgM+/IgDhigh). To exclude the possibility that survival of
contaminating MZ B cells in the NF B-cell preparation may
contribute to the results, the same experiments were performed
with sorted mature MZ B cells. Fig. S12 shows flow cytometry
analyses of the MZ and NF B-cell populations before and after
48-h culture. In contrast to the NF B cells, where a small but
consistent proportion of the cells survived the 48-h incubation
period, none of the MZ B cells survived, regardless of the
presence of BAFF or ECM molecules.
NF B cells incubated in the presence of BAFF or laminin 511
showed increased proportions of CD21highCD1dhigh (Fig. 6A) and
CD23+/CD21+ cells (Fig. S13), and this effect was suppressed in the
presence of GoH3 (Fig. 6A; Fig. S13). Laminin 511 plus BAFF
further increased the proportion of CD21highCD1dhigh (Fig. 6A) and
CD23+/CD21+ cells that formed, which were reduced to levels
observed with BAFF alone in the presence of GoH3 (Fig. 6A).
Agrin and laminin 411 had no effect (Fig. 6A). Analysis of IgD/IgM
revealed differences between the effects of BAFF and laminin 511;
whereas BAFF mainly promoted the IgM+/IgDhigh population,
which probably reflects enhanced survival of spontaneously differ-
entiating FOB cells, laminin 511’s effects were on the IgMhighIgDlow
population, which contains both NF and MZ B cells, and only this
population was reduced in the presence of GoH3 (Fig. 6B). As
IgM− cells are those predestined to die (32), these data also indicate
Fig. 3. NF B cells express laminin α5
binding integrins and show some coloc-
alization with laminin α5 in the MZ. (A)
Representative flow cytometry for cell
surface integrin expression on NF B cells
with antibody isotype controls shown in
gray. (B) In vitro adhesion of MZ, FO, and
NF B cells to VCAM-1, laminin 511/521,
the RGD-containing laminin α5 domain
IVa, agrin, fibronectin (all 30 μM), or
BSA. Adhesion of NF B cells to VCAM-1,
laminin 511/521, or fibronectin was mea-
sured in the presence or absence of
function blocking antibodies to integrins
β1 (Ha2/5), α6 (GoH3), or α4 (PS/2). Data
shown are mean values ± SEM from
three separate experiments with n = 6
for each treatment in each experiment.
(C) Immunofluorescence staining shows
the presence of IgM+CD21low and (D)
IgM+AA4.1+ B cells in the MZ of mature
mice (arrowheads). Magnification, 100×
(D, Left), 200× (C, Upper), 400× (C, Lower,
and D, Right). (E) In vivo localization
of ex vivo TAMRA-labeled NF B cells or
FO B cells (isolated from day 10 mouse
spleens) at 16 h after i.v injection into
mature mice in the presence or absence
of GoH3. Immunofluorescent staining for
laminin α5 reveals localization of NF B
cells in the MZ (double arrows), follicle, and RP, whereas FO B cells home predominantly to the follicle. Coinjection with GoH3 reduced TAMRA+ NF B-cell
localization to the MZ only. Magnification: 100×. Bar graph shows quantification of the ratio of MZ/FO localized TAMRA+ cells; data are means ± SEM from two
experiments with four mice in each category. *P < 0.05; **P < 0.01.
Fig. 4. WTmice carrying Itga6−/− bone marrow show reduced MZ B-cell and
increased NF B-cell frequencies. (A) Representative flow cytometry of
CD21lowCD23lowNF B cells, CD21highCD23lowMZB cells, andCD21highCD23high FO
B cells in the spleen of the bone marrow chimeric mice at 10 wk after re-
constitution, with corresponding quantification of absolute numbers of NF,MZ,
and FO B cells (data are means of three experiments with five mice per experi-
ments ± SEM; **P < 0.01. (B) Circulating IgM levels in Itga6−/− chimeric mice and
WT controls (WT mice carrying WT bone marrow) in response to i.v. or i.p. im-
munizationwithT cell-independent antigen (NP-Ficoll). Data shownaremeans±
SEM from eight Itga6−/− chimeras and WT controls and three independent
experiments. **P < 0.01; ***P < 0.001. (C) Competitive bone marrow re-
constitution studies were performed with a 1:1 ratio of CD45.1+ WT: CD45.2+
Itga6−/− bonemarrow cells injected i.v. intoWT irradiatedmice and subsequent
analysis of CD45.1+ (WT) or CD45.1− (Itga6−/−) cells in NF, MZ, and FO B-cell
compartments, showing preferential accumulation of Itga6−/− cells in the NF B-
cell compartment. Percentages of Itga6−/− B cells within the different B-cell
subpopulations are shown.








































that both BAFF and laminin 511, but not agrin, promote immature
B-cell survival (Fig. 6B).
To test whether interactions with laminin 511 support NF B-
cell differentiation toward the MZ compartment in vivo, sorted
CD45.2+CD21low/CD23low NF B cells were transferred i.v. to
mature (8–9 wk) CD45.1+ mice. NF B cells were precincubated
with GoH3 or isotype control antibody before transfer, and the
appearance of CD45.2+ cells in NF, MZ, and FO B-cell com-
partments was measured at 7 d by flow cytometry. Approximately
4% of the donor cells were recovered in the spleens. Fig. 6C
shows that CD45.2+ donor cells accumulated in the MZ B-cell
compartment, but when transferred cells were preincubated with
GoH3, this was significantly reduced and was accompanied by an
increase of CD45.2+ cells in the NF B-cell compartment, prob-
Fig. 5. Integrin α6β1-laminin α5 interactions sup-
port MZ B-cell determination and survival in vivo.
(A) Representative flow cytometry of TUNEL-posi-
tive NF, MZ, and FO B cells in the spleens of condi-
tional Lama5−/− and Itga6−/− bone marrow chimeric
mice showing increased apoptosis of MZ B cells
only. Bar graphs show means ± SEM from at least
three separate experiments with three to four mice
per experiment. (B) qRT-PCR for antiapoptotic (Bcl-
XL, Bcl-2) and proapoptoic (Bim) genes in NF, MZ,
and FO B cells in the spleens of Itga6−/− bone mar-
row chimeric mice. Data shown are fold differences
from WT mice, n = 3 experiments, with triplicates in
each. (C) qRT-PCR for Deltex-1 (Dtx1) in NF, MZ, and
FO B cells sorted from the spleens of Itga6−/− bone
marrow chimeric mice, showing up-regulation in NF
B cells. Data shown are fold differences from WT
mice; n = 3 experiments. (D) Forward scatter (FSC) of
sorted NF, MZ, and FO B cells from the spleens of
Itga6−/− bone marrow chimeric mice reveals a pop-
ulation of small Dtx1-negative NF B cells and larger
cells of similar to mature MZ B cells that are Dtx1
positive. Bar graph shows fold differences com-
pared with FO B cells, n = 3 experiments, with
triplicates in each. *P < 0.05; **P < 0.01;***P <
0.001. (E) Surface levels of IgM, AA4.1, CD1d, and
HSA on the gated large (FSChigh), small (FSClow), and
MZ B-cell populations are also shown.


























ably reflecting remaining transferred cells. These results suggest
that integrin α6β1-mediated interaction between NF B cells and
laminin α5 in vivo may promote differentiation to MZ B cells.
ELISA performed using laminin 511, agrin, laminin 411, or
fibronectin as substrates revealed binding of BAFF only to the
MZ-specific ECM molecules laminin 511 and agrin (Fig. 6D).
Confocal microscopy of isolated NF B cells plated on laminin
511 or laminin 511 plus BAFF showed clustering of the integrin
α6β1 receptor and colocalization of BAFF receptors within these
clusters, whereas BAFF alone or agrin did not cluster the BAFF
receptors or integrin α6β1 (Fig. 6E). Control experiments per-
formed with the highly adhesive substrate, VCAM-1, showed no
clustering of integrin α6β1 or BAFF receptors (Fig. 6E). To
better define the BAFF receptor involved, transmembrane acti-
vator and CAML interactor (TACI), which also binds BAFF, is
highly expressed on MZ B cells and clusters on engagement of its
ligand a proliferation-inducing ligand (APRIL) (33), was also
investigated. TACI−/− cells showed the same pattern of results as
obtained with WT cells, which does not exclude the involvement
of TACI but indicates that clustering of integrin α6β1 and BAFF
receptors can also occur in its absence. The fact that agrin can
bind BAFF to the same extent as laminin α5 (Fig. 6D) but cannot
promote the mature MZ B cells (Fig. 6A) or cluster BAFF
receptors, indicates that it is not simply ECM binding and en-
richment of BAFF that supports the MZ B-cell population but
rather highlights the importance of laminin α5–integrin α6β1-
mediated signaling in the synergistic effects of BAFF and
laminin α5.
Discussion
In addition to cell adhesion molecules and chemotactic gra-
dients, we show that the MZ is characterized by a unique ECM
occurring pericellularly around individual stromal cells to form
a filligree halo extending from the marginal sinus, the main
constituents of which are the basement membrane glycoproteins,
laminin α5 (laminin 511/521), and the heparan sulfate, agrin.
Although other ECM molecules occur at this site, including
collagen type IV, nidogen 1, fibronectin, perlecan, and an as
yet undefined molecule detected by the ERTR7 antibody, they
are also expressed in the RP stroma, and only laminin α5 dis-
tribution correlates with MZ B-cell localization and size of
this compartment.
Analyses of transgenic mice with expanded or absence of the
MZ B-cell compartment showed that the localization of MZ B
cells coincides precisely with the laminin α5–positive areas and
that laminin α5 is lost when MZ B cells are absent. Interestingly,
the absence of laminin α5 in the MZ of CD19−/− mice suggests
that MZ B-cell presence may contribute to the maintence of
laminin α5 expression in the MZ in a positive feedback fashion,
potentially via cytokine induced mechanisms as has been shown
Fig. 6. Laminin α5 supports formation of MZ B cells in vitro and in vivo. Representative flow cytometry for (A) CD1d/CD21 and (B) IgM/IgD of sorted
CD19+CD21lowCD23low NF B cells after 48-h culture in the presence of BAFF, laminin 511, agrin, or different combinations thereof, in the presence or absence
of GoH3. Gatings in A and B were on live cells. Bar graphs show quantitative data from all experiments performed; n = 3 experiments, with triplicates in each;
**P < 0.01, ***P < 0.001. (C) Sorted CD45.2+ NF B cells were transferred into adult CD45.1+ recipients in the presence or absence of GoH3, and spleens were
analyzed at day 7. Spleen cells were sorted by FSC and gated on CD19+ cells and subsequently separated into CD45.1+ and CD45.1− populations, which were
analyzed for CD21/CD23 levels to define MZ and NF B cells. Bar graph shows proportions of MZ and NF B cells from four experiments with four mice per
experiment; data shown are means ± SEM; *P < 0.05, **P < 0.01. (D) ELISA for the binding of BAFF to Agrin, laminins 411 and 511, and fibronectin (FN). Data
shown are means of three experiments with triplicates in each experiment. **P < 0.01, ***P < 0.001. (E) Confocal microscopy of NF B cells isolated from WT
and TACI−/− mice were plated on plastic alone or culture dishes coated with BSA, agrin, VCAM-1, laminin 511, or BAFF alone or BAFF bound to laminin 511.
Cells were double stained for integrin α6 and BAFF receptors. Magnification: 600×.








































in other systems (34). Although MZ B cells bind to laminin α5 in
in vitro assays via β1 and β3 integrins, the results of in vivo dis-
lodgement studies indicate that this does not contribute to long-
term retention of MZ B cells or other MZ resident cells to this
site, as has been shown for VCAM-1 and ICAM-1 for MZ B cells
(10). Rather, analysis of the Lama5−/− mouse lacking laminin α5
in the MZ suggests that interactions of the immigrating NF B
cells with laminin α5 in the MZ promotes survival of MZ B cells
and potentially also their formation. In vitro and in vivo studies
suggest that NF B cells use integrin α6β1 to interact with laminin
α5 in the unique ECM of the MZ and that at least transient
passage of immigrating NF B cells through this compartment
promotes the MZ B-cell lineage, as previously suggested (8).
Loss of either laminin α5 in the MZ or integrin α6 on B cells
results in the same reduction in the mature MZ B-cell pop-
ulation and in an impaired antibody response to T-cell in-
dependent antigen, consistent with defective MZ B-cell function.
Both the conditional Lama5−/− mouse and mice carrying Itg6−/−
bone marrow showed no changes in FO B-cell numbers or in
other MZ resident cells, including MZ macrophages or sinus-
lining macrophages. Nor were there abnormalities in expression
patterns of adhesion molecules known to play a role in MZ re-
tention, including VCAM-1 and ICAM-1, consistent with the
absence of defects on MZ B-cell retention. The increase in the
proportion of T1 and reduction in T2 transitional B cells, cou-
pled with the absence of a defect in pre- and pro-B cells or in
immature B cells in the bone marrow, indicates that early B-cell
development is not affected by reduced laminin α5 expression in
the MZ or loss of integrin α6β1 on B cells but that the transition
from T1 to T2 in the spleen is impaired, leading to a subsequent
decrease in mature MZ B-cell numbers.
Existing data suggest that T1 cells give rise to T2 cells, which
subsequently give rise to FO and MZ B cells, possibly via a third
transitional population (T3), and that both positive and negative
regulatory pathways within the spleen control the final outcome
of these populations. The T1 population is considered to be
negatively regulated within the spleen, with BCR signals leading
to cell death, whereas T2 cells are positively regulated with BCR
signaling, leading to their differentiation (35). In addition, mu-
tations in the BAFF receptor and the canonical NF-κB signaling
pathway, Notch2, or signaling molecules linked to integrin or
chemokine activation all lead to reduced MZ B-cell numbers
(36). Our data suggest that integrin α6β1–laminin α5 interactions
are additional factors that impact on T1 and T2 fate and that it is
the threshold of signals collectively arising from several sources
that determines whether the final MZ phenotype results. Our
data suggest that transient retention of NF B cells in the MZ via
integrin α6β1–laminin α5-mediated interactions promotes T1 to
T2 transition and hence MZ B-cell formation; however, given
that the NF B cells also bind VCAM-1, this may also be provided
by VCAM-1/α4β1 interactions in the absence of either laminin
α5 or integrin α6β1, explaining why not all MZ B cells are lacking
in the Lama5−/− and Itg6−/− chimeric mice. Similarly, the exis-
tence of small and large NF B cells in mice lacking laminin α5 in
the MZ or integrin α6β1, the larger of which expressed several
NF B-cell markers and downstream genes of Notch2 signaling
(Deltex-1) and were therefore committed to the MZ B-cell lin-
eage, suggests that integrin α6β1-mediated binding to laminin α5
is not a prerequisite for Notch2-dependent differentiation of NF
B cells to MZ B cells, but may be one of several factors that
promote this step.
TUNEL experiments clearly show that integrin α6β1-mediated
interaction of mature MZ B cells with laminin α5 promotes their
survival. Our in vitro experiments revealed that laminin 511 was
almost as effective as BAFF and synergizes with BAFF in sup-
porting the survival of NF B cells, as well as promoting NF B-cell
differentiation toward the MZ compartment. These results sug-
gest that integrin α6β1-mediated laminin α5 interactions may
directly promote MZ B-cell differentiation in vivo. However,
taken together with the reduced survival of MZ B cells in
Lama5−/− and Itg6−/− chimeric mice, the reduced numbers of
MZ B cells in these mice could also be explained by an altered
turnover of MZ B cells. These different possibilities cannot be
resolved without in vivo BrdU-labeling experiments. The fact
that agrin can bind BAFF to the same extent as laminin 511 but
does not support theMZ B-cell population in in vitro experiments,
nor cluster BAFF receptors, indicates that laminin α5 does not act
by simply binding and enriching BAFF, but rather suggests syn-
ergistic effects of laminin α5 and BAFF. As BAFF promotes B-
cell survival, the synergistic effect of laminin 511 plus BAFF is
likely to explain the elevated apoptosis of MZ B cells in mice
lacking laminin α5 in the MZ or integrin α6β1 on B cells.
That laminin α5 directly binds BAFF and clusters BAFF
receptors and integin α6β1, as shown here, suggests the forma-
tion of supramolecular membrane complexes where the in-
tegration of the MZ B-cell promoting signals from integrin α6β1
and BAFF receptors are amplified (Fig. 7). Data from our lab-
oratory suggest that in the case of both BAFF and laminin α5,
this involves induction of MAPK/ Erk1 signaling. Other exam-
ples exist where cell–matrix interactions amplify the effects of
growth factors (37); for example, integrin α6β1-mediated contact
of oligodendrocytes with axonal laminins results in the clustering
of α6β1 and PDGF receptors into lipid rafts and amplifes PDGF-
mediated induced oligodendrocyte maturation (38). However,
this is first demonstration of such an effect on immune cell fate.
In addition to these direct effects of laminin α5, indirect effects
are likely. In this context, it is noteworthy that laminin α5 forms
a filigree connection between theMZ and the basementmembrane
of the bordering venous sinuses (Fig. 1B) (4) and that exogenously
injected TAMRA-labeled NF B cells localize not only to the MZ
but also to the venous sinuses. Because Notch2 is required for MZ
B-cell development but its ligand, Delta1, is mainly expressed on
the endothelium of the venous sinuses in the RP (39), laminin α5
may also provide a pathway for shuttle between these sites. Pre-
liminary data from our laboratory show that Delta1 is still
expressed on the venous sinus endothelium of mice lacking laminin
α5 at this site; hence, it is not required for Delta1 expression.
In addition to the effects on the immigrating NF B cells and
MZ B cells, we demonstrate that FO B cells can also bind to
laminin 511. The precise function of this interaction remains
unclear, but may include transient retention of FO B cells in the
MZ during their recirculation, which was previously suggested to
be mediated by interaction with fibronectin (27) but, which we
show here, is not an adhesive substrate for these cells.
Our data demonstrate that interactions with ECM do not nec-
essarily translate to strong adhesion but rather can result in
transduction of signals that affect processes such as differentiation
Fig. 7. Proposed model of how laminin α5-integrin α6β1-mediated inter-
actions impact on the MZ B-cell population. NF transitional B cells immi-
grating from the bone marrow (yellow cells), characterized by weak B-cell
receptor (BCR) signaling, arrive in the unique laminin α5-rich perifollicular
network where they interact with laminin α5 via integrin α6β1. Laminin α5
can directly bind BAFF and clusters BAFF receptors (BAFFRs) and integin
α6β1, resulting in supramolecular membrane complexes where the in-
tegration of NF and MZ B cell–promoting signals from integrin α6β1 and
BAFF receptors are amplified, which together with the Notch2-dependent
pathways support commitment to the MZ B-cell fate (large orange cells).


























and survival. Although laminins have long been known to play such
roles in differentiation of several tissue types, with their α chains
being responsible for cell adhesion and biological activity (40),
a role in immune cell development or homeostasis has not been
previously demonstrated. Indeed, the function of the ECM of
lymphoid organs has remained poorly studied, despite its abun-
dance in these organs and enormous potential to interact with both
cells and soluble cytokines, which has been due to the lack of tools
and animal models to study the ECM of lymphoid organs and
hence lack of information on its biochemical nature.We show here
that the fine, perifollicular laminin α5 expression pattern in the
spleen clearly defines a unique niche that supports the formation
and survival of the highly specialized MZ B-cell population.
Integrin α6β1-mediated interaction of NF B cells with laminin α5
in the MZ supports the MZ B-cell population and synergies with
BAFF to enhance their long-term survival and physiological
function (Fig. 7). Structurally similar ECM structures surround the
stromal cells of the bone marrow, thymus, and fetal liver; the cell–
matrix relationships described here are therefore likely to have
broader ramifications to other immune cell fates.
Materials and Methods
Animals and Tissues. The following mice were on a C57BL/6 background and
were used at 8–15wk of age:WT C57BL/6, NODmice (41), transgenic 24αβNOD
mice expressing the Vα3.2Vβ9 TCR (42), CD19−/− mice (19), agrin−/− mice (43),
and TACI−/− mice (44). A laminin α5 endothelial cell–specific KO mouse, gen-
erated by crossing a laminin α5 mouse carrying lox P flanking exons 2–4 (21)
with the Tie-2 cre recombinase mouse (22), was used and is referred to as
conditional Lama5−/− (Fig. S3). Animal breeding and experiments were con-
ducted according to the Swedish and German Animal Welfare guidelines.
Immunofluorescence. Antibodies used in immunofluorescence studies rec-
ognizing ECM molecules are detailed in Table 1. Antibodies to the following
were used to identify cellular compartments: B220 (Pharmingen), IgM and
IgD (Pharmingen), ERTR9 and ERTR7 (BMA Biomedicals), MOMA-1 (BMA
Biomedicals), MadCAM [mouse endothelial cell antigen (MECA)-367], ICAM-
1 (YN1/1.7), VCAM-1 (M/K-2; Southern Biotech, and MVCAM.A; BD Bio-
sciences), and CD21 (BD Biosciences). Secondary antibodies included donkey
anti-goat FITC-conjugated IgG (Dianova), goat anti-hamster IgG Alexa Fluor
594 (Molecular Probes), goat anti-rabbit FITC-conjugated IgG, rhodamine-
conjugated IgG (H+L) (Dianova), Cy5-conjugated IgG (Dianova), goat anti-rat
Texas red–conjugated IgG, Alexa Fluor 594 IgG (Molecular Probes), donkey
anti-rat Alexa Fluor 488 IgG, Cy3-conjugated IgG (H+L), and mouse anti-rat
FITC-conjugated κ chain IgM (Immunotech). In some cases, mice were
injected with 100 μg each of anti-integrin α4 (PS/2; Pharmingen) and anti–
LFA-1 (M17/4; Pharmingen) to displace MZ B cells; after 3 h, spleens were
collected, frozen, and stained for VCAM-1, ICAM-1, or laminin α5.
Spleenswere frozen inTissueTek (MilesLaboratories) in isopentaneat−70°C.
Five-micrometer cryostat sections were fixed for 10min in –20 °Cmethanol. For
confocal microscopy or 3D reconstructions, tissues were fixed in 1.5% (wt/vol)
paraformaldehyde for 1.5 h at 4 °C and embedded in 1% (wt/vol) agarose, and
60- to 100-μm sections were prepared using a vibratome. Thick sections were
treated with PBS plus 1% (wt/vol) BSA before overnight incubation with
primary antibody at 4 °C. Immunofluorescence staining was carried out as de-
scribed previously (34). Sections were examined using a Zeiss AxioImager
microscope equipped with epifluorescent optics and documented using
HamamatsuORCA ER cameraorwith a Zeiss confocal laser scanning systemLSM
700. Images were analyzed using Volocity 6.0.1 software (Improvision).
Flow Cytometry. Single cell suspensions of splenocytes or bone marrow cells
were obtained by sieving through a 70-μm filter. Splenocytes or bone mar-
row (106) cells were stained for integrins by first blocking Fc-receptors with
10% (vol/vol) normal goat and mouse serum (Sigma-Aldrich). The following
unconjugated anti-integrin antibodies were used, purchased from BD Bio-
sciences unless otherwise stated: α2 (HMα2, Dx5), α4β7 (DATK32), α4 (PS/2),
α5 (X-6, Dianova), α6 (GoH3), αL (M17/4.2 ATCC), β1 (Ha2/5 and 9EG7), β2
(GAME-46), β3 (2C9.G2), lutheran blood group glycoprotein (45), and sul-
phatide (3′-sulphogalactosylceramide) (Sulph 1) (46), and isotype anti-rat
and anti-hamster controls. Biotinylated polyclonal goat anti-rat Ig multiple
adsorbed (Pharmingen) or biotinylated goat anti–Armenian hamster IgG
(Jackson Immunoresearch Laboratories) was then added. Unspecific binding
was further blocked by 10% (vol/vol) normal rat serum (Sigma-Aldrich),
and in the final step, anti–CD21-FITC (Pharmingen), anti–CD23-phycoery-
thrin (PE) (Pharmingen), streptavidin-PerCP (Pharmingen), and anti–B220-
Cy5 (RA3.6.B2, Pharmingen) were added.
Allophycocyanin (APC)-labeledanti-CD93 (AA4.1) (eBioscience), biotin- or PE-
labeled anti-CD23, FITC- or PE-labeled anti-CD21, biotin-labeled anti-CD1d
(Pharmingen), FITC-labeled anti-IgM, and PerCP-labeled anti-B220 (Pharmin-
gen) wereused forflow cytometry of transitional B-cell populations in the bone
marrow and spleen. An in situ cell death detection kit (Roche) that detects
TUNEL-positive cellswas used to determine the proportion of apoptoticMZand
FO B cells in the spleens. Flow cytometry was performed on a FACSCalibur
(Becton Dickinson), and data analysis was done using CellQuest software
(BD Biosciences).
In Vitro Adhesion Assays. In vitro adhesion assays for MZ and FO B cells were
performed as previously described (10) using the following substrates: pu-
rified laminin 511/521 (47) and recombinant agrin (43), as representatives of
ECM molecules enriched in the marginal zone; fibronectin, which is present
in the marginal zone and the RP; and VCAM-1 (ADP5; R&D Systems), which
has previously been identified as an adhesive substrate for splenocytes (10).
Recombinant laminin α5 fragments were used to define binding domains
(domains IVa, G4–G5, V–VI) (23). All proteins were used at the same molar
concentration (30 μM) and were plated at 37 °C for 1 h; wells were washed
with PBS and blocked with 1% (wt/vol) BSA (A-3311; Sigma Aldrich) in PBS.
Adhesion assays were performed at 37 °C for 90 min, and bound MZ and FO
B cells were analyzed by flow cytometry using B220/CD1d/CD21/CD23 to
distinguish cell populations (10). To examine the adhesion of NF B cells to
ECM and VCAM-1, enriched splenic B lymphocytes obtained using anti-
CD19–coated magnetic (MAC) beads (Miltenyi Biotech) were used in adhe-
sion assays and adherent cells determined by FACS for B220+AA4.1+ cells.
To determine receptors mediating adhesion to the different substrates, cell
adhesion assays were performed in the presence or absence of 25 μg/mL of
blocking antibodies to integrins α6 (GoH3), β1 (Ha2/5), β3 (2C9.G2), α4 (PS/2),
or cylic-RGD peptides, specific for αv series integrins, and control peptides (47).
In Vivo Homing and In Vivo Differentiation Assays. NF B cells (CD19+CD21low
CD23low) and FO B cells (CD19+CD23high/CD21low) were isolated from spleens of
day 10 mice. In some cases, cells were labeled with 5 μM 5(6)-TAMRA-SE
(Invitrogen) before transfer to permit in vivo localization or were isolated from
Ly5.1 mice and transferred to Ly5.2 recipients to permit in vivo quantification.
Cells (5 × 106) were transferred per 8- to 9-wk-old recipient. Quantification of
TAMRA+ cells at 16 h after transfer in the spleens required sectioning of entire
spleens and counting of TAMRA+ cells in the different spleen compartments
using either IgMhigh or anti-laminin α5 as a marker of the MZ. At least 10
different areas per section and at least 20 sections per animal were counted.
For in vivo differentiation studies, 50 × 106 CD45.2+ NF B cells were
transferred per 8- to 9-wk-old CD45.1 recipient, and ∼2 × 106 cells were
recovered in the spleen after 7 d. CD45.2+ NF cells were preincubated with
50 μg/mL GoH3 or isotype control antibody for 1 h at 4 °C before injection.
Spleen cells were analyzed by FSC and gated on CD19+ cells and were sub-
sequently separated into CD45.1+ and CD45.1− populations, which were
analyzed for CD21/CD23 levels to define MZ and NF B cells.
qRT-PCR. qRT-PCR was carried out on sorted MZ (CD21highCD23low), FO
(CD21high CD23high), and NF (CD21lowCD23low) B cells for expression of Bcl-xl,
Bcl-2, Bim, and Deltex1 (13).
Bone Marrow Chimeric Mice/Competitive Bone Marrow Reconstitution. As
integrin α6 KO (Itga6−/−) (30) mice die perinatally, bone marrow recon-
stitution was performed using embryonic day 16 liver cells from Itga6−/−
embryos. Itga6−/− fetal liver cells (10–15 × 106) (Ly5.2) were injected i.v. into
lethally irradiated (11Gy) congenic WT recipient mice (Ly5.1). Engraftment
took 8–10 wk, and mice with >95% donor cell engraftment were used.
Competitive bone marrow reconstitution studies were performed with a 1:1
ratio of CD45.1+ WT: CD45.2+ Itga6−/− bone marrow injected i.v. into WT
irradiated mice. Mice were analyzed at 10 wk after engraftment.
ELISA. Ninety-six-well ELISA plates were coated overnight at 4 °C with BSA,
agrin, laminin 411, laminin 511, or fibronectin (3 μg/mL) and blocked with
2% (wt/vol) BSA, and BAFF (R&D 500 ng/mL) was added at room tempera-
ture for 2 h. Rat anti-BAFF (Abcam, 1 μg/mL) and HRP-conjugated goat anti-
rat were used to detect bound BAFF.
Immunization/Antibody Response. Mice were immunized by i.v. or i.p. injec-
tions of 50 μg NP-Ficoll in a volume of 200 μL. At 1, 2, and 3 wk after im-
munization, serum antibody titers were measured using the Clonotyping
System Kit (Southern Biotech).








































In Vitro MZ B-Cell Differentiation. NF B cells (1 × 106; CD19+CD21lowCD23low)
from spleens of day 10 mice were incubated with the following substrates for
48 h at 37 °C: 10 μg/mL of BSA, laminin 511, laminin 411 or agrin, 100 ng/mL
BAFF, or combinations thereof. Control experiments involved isolation of
CD19+CD21hiCD23low MZ B cells from adult spleens using FACSAria (BD Bio-
sciences) and their culture under the same conditions as the NF B cells. Ex-
periments were performed in the presence or absence of 50 μg/mL integrin α6
blocking antibody (GoH3). Cells were analyzed by flow cytometry using CD1d,
CD21, CD23, IgM, and IgD antibodies. 7AAD (BD Biosciences) was used to
identify dead cells.
Colocalization Assay. Coverslips were coated overnight at 4 °C with BSA,
BAFF, agrin, VCAM, or laminin 511 alone (3 μM), or laminin 511 to which
BAFF was subsequently bound by incubation at room temperature for 2 h.
NF B cells (1 × 106) from WT or TACI−/− mice were added and incubated at
37 °C for 2 h. After washing, coverslips were fixed in 4% PFA, blocked with
2% BSA, and stained with anti-integrin α6, GoH3 (1 μg/mL), and anti-BAFF
receptor (anti-CD268, clone ebio7H22-E16; eBioscience, 1 μg/mL). Bound
antibodies were detected with Alexa488- or Cy3-conjugated secondary
antibodies, and cells were examined using a Zeiss LSM 700 confocal laser
scanning microscope. Images were analyzed using Volocity 6.0.1 software
(Improvision).
Statistical Analyses. The data were analyzed by a paired sign t test or Student
t test. All P values of 0.05 or less were considered statistically significant.
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